Mylab gets DCGI commercial approval for COVID-19 test kit

New Delhi: Pune-based molecular diagnostics company Mylab Discovery Solutions on Monday said it has received commercial approval from the Central Drugs Standard Control Organisation (CDSCO) for its COVID-19 test kit. The test kit by the company is the first 'Made in India' kit to receive commercial approval from CDSCO, and is named as Mylab PathoDetect COVID-19 Qualitative PCR kit, the company said in a statement.

"With an emphasis on 'Make in India' and support from local and central government, the COVID- 19 kits have been made as per WHO/CDC guidelines. It was developed and evaluated in record time," Mylab Discovery Solutions MD Hasmukh Rawal said.

Local sourcing of test kits will be a major breakthrough for India as the testing kit by Mylab would cost nearly one-fourth of the current procurement cost, the company said.

Read also: Coronavirus: PM Modi Interacts with Pharma leaders to ensure no shortage of drugs

Moreover, Mylab's COVID-19 test kit screens and detects the infection within 2.5 hours as compared with over 7 hours taken by current protocols, it added.

Read also: CDSCO issues regulatory pathway for R&D of IVD kit for diagnosis of COVID-19